Retaine Omega Forté omega-3 dry eye supplement launches

Retaine Omega Forté, an omega-3 nutritional supplement aimed at alleviating symptoms of dry eye, is now available, according to a press release from OcuSoft.
Retaine Omega Forté is intended for any patient with dry eye or meibomian gland dysfunction as well as “patients who take omega-3 for other health benefits because of its potency,” George Haines, executive vice president of OcuSoft, told Healio.
The supplement contains 2,490 mg of two omega-3 fatty acids — eicosapentaenoic acid and docosahexaenoic acid — as well as 405 mg of additional omega-3 fatty acids. It is

Long sleeves of health workers commonly hold bacteria

The long sleeves of health care workers were frequently contaminated with bacteria, and some sleeves harbored multiple pathogens, according to findings from a prospective observational study.
The study, which examined 280 samples from multiple inpatient hospital settings, showed that 81% of health care workers’ long sleeves grew bacteria and 21% contained at least one potential pathogen, such as alpha-hemolytic streptococci (28 instances), Bacillus species (20), Pantoea/Mixta species (eight), gram-negative bacilli (six), and Staphylococcus aureus (two).
“The goal of this quality improvement

Advanced practice providers needed to manage cardiac care

Advanced practice providers are highly knowledgeable medical professionals who are part of a health care team and play a key role in developing and implementing patients’ treatment plans.
Advanced practice providers (APPs) include nurse practitioners, physician assistants, certified registered nurse anesthetists and anesthesiologist assistants. They play an essential role in implementing continuity of care, which has been shown to benefit patients, and in managing an increasing volume of patients who use health systems for a variety of reasons, including when their wearable device suggests

Hearing aids not linked to cognitive differences

Hearing aids did not lead to any significant differences in cognitive testing among older patients with moderate hearing loss, but these devices may reduce risks for dementia, according to data published in Neurology.
Residual confounding may explain these findings, Lachlan Cribb, BSci, MEpi, a PhD student at the School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia, and colleagues wrote.
“Hearing loss has been linked to a greater risk of developing dementia. But it was not known whether using a hearing aid could help reduce that risk,” Cribb told

Alcohol plays disproportionately large role in suicide among lesbian, gay, bisexual women

Lesbian, gay and bisexual women were more likely to have detectable blood alcohol content or be intoxicated at time of death by suicide than heterosexual women, according to a cross-sectional study published in JAMA Open Network.
“We believe it is important for psychiatrists and health care professionals to know that alcohol is an important contributor to suicide,” study author Sarah McKetta, MD, PhD, assistant professor of epidemiology at Columbia University Mailman School of Public Health, told Healio.
McKetta and colleagues cited prior research indicating that individuals who drink alcohol

Topical solution for chronic fungal nail infection consistently effective across races

Efinaconazole 10% solution was found to be a safe and effective treatment of chronic fungal nail infections among patients with skin of color, according to a study published in the Journal of Drugs in Dermatology.
Onychomycosis is a chronic fungal infection of the nail plate or bed that affects up to 14% of Americans, the study reported. Symptoms and complications of onychomycosis can include toenail deformity, discomfort, infections and pain that interferes with daily activities. Although patients with skin of color comprise the minority of people diagnosed with onychomycosis, they have a

LGBTQ+ individuals with IBD face discrimination, insurance issues

LAS VEGAS — LGBTQ+ individuals with inflammatory bowel disease experience multiple gaps and inequities in care when managing their condition, study results showed.
Among the most reported were negative clinical encounters, delays in diagnosis, insurance barriers, ineffective initial treatments and discrimination.
“These challenges were compounded by the emotional labor required to repeatedly explain their identities and medical histories in environments that were not always affirming,” Victor Chedid, MD, MS, consultant in the division of gastroenterology and hepatology and assistant professor

FDA approves updated label with new dosing guidance for inhaled insulin

The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to an industry press release.
The revised label for technosphere insulin (Afrezza, MannKind) provides patients with revised dosing recommendations when they are switching from multiple daily injections or mealtime insulin pump therapy.
According to prescribing information provided by MannKind in a press release, adults receiving up to 3U of subcutaneous mealtime insulin would start technosphere insulin at 4U. Those using 4U to 5U of injectable insulin would begin

Distinct age profiles observed for glomerular disease

Adolescents and young adults aged 14 to 25 years with glomerular disease present with distinct clinical profiles compared with pediatric or adult populations, according to study data published in Kidney360.
The adolescent and young adult population living with kidney disease is increasing, and these patients face unique challenges, including medication adherence and navigating the health care system, according to Andrew Vissing, MD, assistant professor of medicine in the division of nephrology and hypertension at Northwestern University Feinberg School of Medicine, and colleagues. Despite

Bill may restore National Asthma Control Program funding

The House of Representatives has passed the Consolidated Appropriations Act 2026, which includes $33.5 million to fund the National Asthma Control Program. Last year, government cost-cutting nearly dissolved this CDC initiative.
Healio spoke with Nissa Shaffi, MS, director of advocacy at the Allergy & Asthma Network, to find out what the new legislation means for this program and how it will impact patients and partners that rely on this funding.
Healio: What is the National Asthma Control Program and why is it important?
Shaffi: The National Asthma Control Program (NACP) is a federal